Opendata, web and dolomites

TRILLIO SIGNED

TRILLIO, a porTable pRescription assistant Improving heaLth of Europeans citizens by increasing therapeutic adherence in eLderly people and in patIents affected by chrOnic diseases

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 TRILLIO project word cloud

Explore the words cloud of the TRILLIO project. It provides you a very rough idea of what is the project "TRILLIO" about.

executives    medical    sends    chronic    button    paper    executing    startup    nokia    source    burdens    la    right    automatically    press    recommendations    clock    turnover    distributing    app    small    trillio    andrea    selling    2023    alerts    500    difficulties       founders    showing    adherence    deaths    device    50    former    pilot    agreed    therapeutic    health    diet    site    pharmaceutical    diseases    act    italy    launching    ten    connected    sound    notification    visual    aifa    completing    brianza    players    lifestyle    provider    abroad    expenditure    follows    causes    innovative    familiar    medication    person    really    optimizes    mobile    150    200    population    corresponds    italian    sure    share    tested    suitable    team    000    connections    endorsement    elderly    alarm    purpose    carlo    treatment    gaggi    feasibility    drug    received    112    generate    serval    therapy    care    family    patient    market    treatments    suffering    turn    billion    comanda    plan    minutes    demo    time    17m    display    hospitals    off    poor   

Project "TRILLIO" data sheet

The following table provides information about the project.

Coordinator
LA COMANDA SRL 

Organization address
address: VIA BARTOLOMEO EUSTACHI 52
city: MILANO
postcode: 20129
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Italy [IT]
 Project website http://www.trillio.org/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-05-01   to  2018-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    LA COMANDA SRL IT (MILANO) coordinator 50˙000.00

Map

 Project objective

'Therapeutic adherence is defined as “the extent to which a person’s behaviour – taking medication, following a diet, and/or executing lifestyle changes, corresponds with agreed recommendations from a health care provider”. It is estimated that each year the poor adherence to medical treatments in Europe causes about 200,000 deaths and burdens on health expenditure up to 80 billion euro a year (AIFA source). TRILLIO is a therapeutic adherence device really similar to an “alarm clock”, thus really familiar for elderly. The TRILLIO device is provided with an app that optimizes the connections among various players and organizations who share a common goal: make sure a patient follows his or her pharmaceutical treatment plan. When it's time to take a drug, TRILLIO alerts the user with a sound and a visual alarm, while showing all the relevant information on its 2.7' e-paper display. If the user doesn't press the button on the device to turn off the alarm within ten minutes, TRILLIO automatically sends a notification to any family member connected to the system. TRILLIO has been already tested in Italy and received serval endorsement by organisations in Italy and abroad. We are a targeting and overall population composed by 150.000.000 European that are suffering from Chronic diseases, 50% of them have difficulties in following a therapy: we are addressing 0,2% of this market and we are aiming at selling 112.000 devices by 2023, that will generate 17M€ turnover. The Feasibility study will have the purpose to support us in completing the market analysis, in launching a small pilot (i.e. 500/1.000 users), in identifying suitable partners in Europe for wide demo site (i.e. hospitals) and in identifying the right partners for distributing TRILLIO in Europe. TRILLIO is brought on the market by LA COMANDA, an Italian startup established under the Italian act for innovative startup, whose founders are Carlo Brianza and Andrea Gaggi, former executives of Nokia mobile team. '

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "TRILLIO" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "TRILLIO" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

DNA DS (2019)

DNA Data storage

Read More  

ERGOVIAkinematix (2018)

New wearable measurement devices for Industry 4.0 based on gaming motion-capture system

Read More  

Keelcrab (2019)

Keelcrab the Drone for an automated hull cleaning: fast & essential

Read More